Glorian Qi

Glorian Qi is a clinical development leader with global drug development experience in metabolism, renal, and cardiovascular diseases. Currently serving as a Director of Regulatory Affairs at AstraZeneca, Glorian has previously held roles such as Associate Director of Clinical Development and Medical Scientist in Early Clinical Development, focusing on therapeutic areas like obesity and diabetes. With a background that includes an instructorship and leadership in the Joslin Medalist Kidney Program at Harvard Medical School, Glorian holds a Bachelor of Biotechnology and is pursuing a Ph.D. in translational research from the University of Sydney.